TD Cowen Maintains Buy on MetLife, Raises Price Target to $114
TD Cowen analyst Andrew Kligerman maintains MetLife (NYSE:MET) with a Buy and raises the price target from $110 to $114.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga